COSMOS Pharmaceutical Corporation Stock price

Equities

3349

JP3298400007

Drug Retailers

Market Closed - Japan Exchange 02:00:00 2024-03-28 am EDT 5-day change 1st Jan Change
14,335 JPY +0.24% Intraday chart for COSMOS Pharmaceutical Corporation +0.56% -11.97%
Sales 2024 * 959B 6.33B Sales 2025 * 1,042B 6.88B Capitalization 568B 3.75B
Net income 2024 * 24.82B 164M Net income 2025 * 26.81B 177M EV / Sales 2024 * 0.56 x
Net cash position 2024 * 31.37B 207M Net cash position 2025 * 32.95B 218M EV / Sales 2025 * 0.51 x
P/E ratio 2024 *
22.9 x
P/E ratio 2025 *
21.2 x
Employees -
Yield 2024 *
0.81%
Yield 2025 *
0.9%
Free-Float 47.53%
More Fundamentals * Assessed data
Dynamic Chart
Cosmos Pharmaceutical’s Attributable Profit Up 2.6% in Fiscal H1 on Expansion of Stores MT
COSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending May 31, 2024 CI
COSMOS Pharmaceutical Corporation Announces Dividend for the Second Quarter End of Fiscal Year Ending May 31, 2024, Payable on February 13, 2024; Provides Year Dividend Guidance for fiscal Year Ending May 31, 2024 CI
Cosmos Pharmaceutical’s Attributable Profit up marginally by 0.4% in Fiscal Q1 After Opening New Stores MT
COSMOS Pharmaceutical Corporation Reports Earnings Results for the First Quarter Ended August 31, 2023 CI
COSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending May 31, 2024 CI
Cosmos Attributable Profit Increases 2.8% in Fiscal Year 2023 MT
COSMOS Pharmaceutical Corporation Announces Year-End Dividend for the Year Ended May 31, 2023, Payable on August 3, 2023; Provides Dividend Guidance for the Second Quarter-End and Full Year of Full Year Ending May 31, 2024 CI
COSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending May 31, 2024 CI
Cosmos Pharma's Attributable Profit Slides 1% in Fiscal Nine Months Amid New Store Openings MT
COSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending May 31, 2023 CI
COSMOS Pharmaceutical Corporation Provides Dividend Guidance for the Fiscal year ending May 31, 2023 CI
Cosmos Pharma Books Marginal Rise in Fiscal H1 Attributable Profit Amid New Store Openings, Low-cost Strategy MT
COSMOS Pharmaceutical Corporation Announces Dividend for the Second Quarter of Fiscal 2023; Provides Dividend Guidance for the Full Year of Fiscal Year Ending May 31, 2023 CI
Cosmos Pharmaceutical Corporation Provides Earnings Forecast for the Fiscal Year Ending May 31, 2023 CI
More news
1 day+0.24%
1 week+0.56%
Current month-2.02%
1 month-2.35%
3 months-13.02%
6 months-8.67%
Current year-11.97%
More quotes
1 week
13 980.00
Extreme 13980
14 590.00
1 month
13 520.00
Extreme 13520
14 750.00
Current year
13 520.00
Extreme 13520
16 345.00
1 year
11 520.00
Extreme 11520
17 440.00
3 years
10 770.00
Extreme 10770
20 700.00
5 years
8 425.00
Extreme 8425
20 700.00
10 years
5 075.00
Extreme 5075
20 700.00
More quotes
Managers TitleAgeSince
President 43 03-03-31
Director of Finance/CFO 58 94-03-31
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 50 05-03-31
Director/Board Member 52 98-10-31
Director of Finance/CFO 58 94-03-31
More insiders
Date Price Change Volume
24-03-28 14,335 +0.24% 120 500
24-03-27 14,300 -0.73% 148,300
24-03-26 14,405 +1.02% 146,000
24-03-25 14,260 +0.35% 145,100
24-03-22 14,210 -0.63% 150,700

Delayed Quote Japan Exchange, March 28, 2024 at 02:00 am EDT

More quotes
COSMOS Pharmaceutical Corporation is a company primarily engaged in the operation of drug stores. The Company offers medical goods, including general self-medication products, tonic drinks, oral care products, nursing care products, vitamin supplements, health food products, diet food and dispensing. Cosmetic products include cosmetic products for women and men, hair care products and bath agents. Miscellaneous goods include baby goods, detergents, insecticides, deodorizers, bath goods, toiletries, cookware, gardening goods, automobile goods and clothing products. General food products include processed food products, daily food products, seasonings, confectionery, non-alcoholic beverages and alcoholic beverages. It also provides tobacco and others.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
14,335 JPY
Average target price
16,585 JPY
Spread / Average Target
+15.69%
Consensus
  1. Stock
  2. Equities
  3. Stock COSMOS Pharmaceutical Corporation - Japan Exchange